News & Perspective

Jul 27, 2017

Jul 27, 2017

News Scan for Jul 27, 2017

Saudi MERS case
Public health funding threat
Hepatitis battle snapshot
Global flu vaccine uptake

Jul 23, 2015

Jul 23, 2015

News Scan for Jul 23, 2015

MERS in Saudi Arabia
H5N2 vaccine in chickens
Experimental Marburg drug
Klebsiella in retail meat
Epidemic threat poll
EV-D68 rapid test

Jan 30, 2014

Jan 30, 2014

News Scan for Jan 30, 2014

States' readiness efforts
MERS-CoV antibodies in camels
Imported Zika cases
Avian flu in skunks

Dec 04, 2013

Dec 04, 2013

Flu Scan for Dec 04, 2013

Hong Kong H7N9 steps
H2N2 threat assessment
Low-path avian flu outbreaks

Nov 21, 2012

Nov 21, 2012

FDA clears first cell-based flu vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the nation's first cell-based flu vaccine, a product from Novartis that uses technology that could help vaccinate more Americans in a pandemic but still has many of the same limitations of older egg-based flu vaccines.

Feb 09, 2012

Feb 09, 2012

Undetected H5N1 cases seem few, but questions persist

(CIDRAP News) – The fatality rate for officially confirmed human cases of H5N1 avian influenza infection is a stunningly high 59% (345 deaths in 584 cases). But the current controversy over publishing data about transmissible H5N1 viruses has revived a debate about whether the virus is as lethal as those numbers say.

Dec 13, 2011

Dec 13, 2011

Novartis says cell-based flu vaccine facility ready to produce

(CIDRAP News) – Novartis's new cell-culture based influenza vaccine factory in North Carolina has begun making a prepandemic H5N1 flu vaccine and is ready to start producing vaccines for a real pandemic when needed, the company and federal health officials announced yesterday.

The facility in Holly Springs, N.C., billed as the first of its kind in the United States, was dedicated yesterday after a long testing process.

Pages

Sort Results

 

Narrow results

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»